Ylva Flodérus

1.1k total citations
44 papers, 747 citations indexed

About

Ylva Flodérus is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Rheumatology. According to data from OpenAlex, Ylva Flodérus has authored 44 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 18 papers in Pediatrics, Perinatology and Child Health and 16 papers in Rheumatology. Recurrent topics in Ylva Flodérus's work include Porphyrin Metabolism and Disorders (33 papers), Heme Oxygenase-1 and Carbon Monoxide (25 papers) and Folate and B Vitamins Research (16 papers). Ylva Flodérus is often cited by papers focused on Porphyrin Metabolism and Disorders (33 papers), Heme Oxygenase-1 and Carbon Monoxide (25 papers) and Folate and B Vitamins Research (16 papers). Ylva Flodérus collaborates with scholars based in Sweden, United States and United Kingdom. Ylva Flodérus's co-authors include Pauline Harper, Lennart Wetterberg, Staffan Wåhlin, Svante B. Ross, S Thunell, Per Stål, Eliane Sardh, Stig Thunell, Dan Andersson and Maria Anvret and has published in prestigious journals such as Blood, Journal of Hepatology and Clinical Chemistry.

In The Last Decade

Ylva Flodérus

44 papers receiving 716 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ylva Flodérus Sweden 15 603 218 199 130 40 44 747
U. Groß Germany 10 324 0.5× 111 0.5× 53 0.3× 65 0.5× 18 0.5× 22 420
Antonella Mulas Italy 7 128 0.2× 88 0.4× 173 0.9× 23 0.2× 93 2.3× 10 481
Concetta Meli Italy 15 460 0.8× 106 0.5× 200 1.0× 27 0.2× 140 3.5× 45 874
J. M. Saudubray France 12 392 0.7× 140 0.6× 162 0.8× 12 0.1× 50 1.3× 26 660
Xingrao Ke United States 15 349 0.6× 537 2.5× 13 0.1× 104 0.8× 103 2.6× 31 896
Juan Darío Ortigoza‐Escobar Spain 14 243 0.4× 109 0.5× 67 0.3× 38 0.3× 60 1.5× 49 712
Merçè Pineda Spain 13 302 0.5× 85 0.4× 179 0.9× 8 0.1× 78 1.9× 19 562
In Goo Lee South Korea 12 107 0.2× 151 0.7× 33 0.2× 49 0.4× 126 3.1× 31 411
Pierpaola Tannorella Italy 12 194 0.3× 65 0.3× 102 0.5× 10 0.1× 100 2.5× 18 361

Countries citing papers authored by Ylva Flodérus

Since Specialization
Citations

This map shows the geographic impact of Ylva Flodérus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ylva Flodérus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ylva Flodérus more than expected).

Fields of papers citing papers by Ylva Flodérus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ylva Flodérus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ylva Flodérus. The network helps show where Ylva Flodérus may publish in the future.

Co-authorship network of co-authors of Ylva Flodérus

This figure shows the co-authorship network connecting the top 25 collaborators of Ylva Flodérus. A scholar is included among the top collaborators of Ylva Flodérus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ylva Flodérus. Ylva Flodérus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wester, Axel, Daphne Vassiliou, Ylva Flodérus, et al.. (2023). Porphyrin precursors and risk of primary liver cancer in acute intermittent porphyria: A case–control study of 188 patients. Journal of Inherited Metabolic Disease. 46(6). 1186–1194. 4 indexed citations
2.
Barbaro, Michela, et al.. (2011). Identification of an AluY‐mediated deletion of exon 5 in the CPOX gene by MLPA analysis in patients with hereditary coproporphyria. Clinical Genetics. 81(3). 249–256. 10 indexed citations
3.
Sardh, Eliane, Pauline Harper, Dan Andersson, & Ylva Flodérus. (2008). Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks. European Journal of Internal Medicine. 20(2). 201–207. 19 indexed citations
4.
Thunell, S, et al.. (2006). Porphyria in Sweden. Physiological Research. 55 Suppl 2. S109–S118. 20 indexed citations
5.
Wåhlin, Staffan, et al.. (2006). The difficult clinical diagnosis of erythropoietic protoporphyria. Physiological Research. 55 Suppl 2. S166–S157. 6 indexed citations
6.
Harper, Pauline, et al.. (2005). The Prevalence of Hepatitis C in Patients with Porphyria Cutanea Tarda in Stockholm, Sweden. Acta Dermato Venereologica. 85(2). 164–166. 6 indexed citations
7.
Tjensvoll, Kjersti, Ove Bruland, Ylva Flodérus, et al.. (2003). Haplotype Analysis of Norwegian and Swedish Patients with Acute Intermittent Porphyria (AIP): Extreme Haplotype Heterogeneity for the Mutation R116W. Disease Markers. 19(1). 41–46. 8 indexed citations
8.
Flodérus, Ylva, et al.. (2003). Novel mutations and phenotypic effect of the splice site modulator IVS3-48C in nine Swedish families with erythropoietic protoporphyria. Journal of Human Genetics. 48(2). 70–76. 28 indexed citations
9.
Harper, Pauline, et al.. (2003). Nine novel mutations in the protoporphyrinogen oxidase gene in Swedish families with variegate porphyria. Clinical Genetics. 64(2). 122–130. 10 indexed citations
10.
11.
Thunell, Stig, et al.. (1997). Effects of Administration of Antioxidants in Acute Intermittent Porphyria. Clinical Chemistry and Laboratory Medicine (CCLM). 35(6). 427–33. 11 indexed citations
12.
Thunell, Stig, et al.. (1995). Markers for Vulnerability in Acute Porphyria. A Hypothesis Paper. Clinical Chemistry and Laboratory Medicine (CCLM). 33(4). 179–194. 18 indexed citations
13.
Wassif, W, A C Deacon, Ylva Flodérus, S Thunell, & Timothy J. Peters. (1994). Acute Intermittent Porphyria: Diagnostic Conundrums. Clinical Chemistry and Laboratory Medicine (CCLM). 32(12). 915–922. 5 indexed citations
14.
Lægreid, Astrid, Maria Anvret, Gunnel Lundin, et al.. (1993). Genetic carrier detection in Norwegian families with acute intermittent porphyria. Scandinavian Journal of Clinical and Laboratory Investigation. 53(7). 687–691. 5 indexed citations
15.
Thunell, Stig, Ylva Flodérus, Carl G. Groth, et al.. (1992). Liver Transplantation in a Boy with Acute Porphyria Due to Aminolaevulinate Dehydratase Deficiency. Clinical Chemistry and Laboratory Medicine (CCLM). 30(10). 599–606. 25 indexed citations
16.
Lee, Jin‐Sung, Maria Anvret, J. Lindsten, et al.. (1988). DNA polymorphisms within the porphobilinogen deaminase gene in two Swedish families with acute intermittent porphyria. Human Genetics. 79(4). 379–81. 34 indexed citations
17.
Flodérus, Ylva, L Iselius, J. Lindsten, & Lennart Wetterberg. (1982). Evidence for a Major Locus as Well as a Multifactorial Component in the Regulation of Human Red Blood Cell Catechol-O-Methyl-Transferase Activity. Human Heredity. 32(2). 76–79. 7 indexed citations
18.
Flodérus, Ylva, Jan Sääf, Svante B. Ross, & Lennart Wetterberg. (1981). Ionic influence on human erythrocyte catechol-O-methyltransferase activity. Biochemical Pharmacology. 30(17). 2481–2482. 2 indexed citations
19.
Flodérus, Ylva, Jan Sääf, Svante B. Ross, & Lennart Wetterberg. (1981). Catechol-O-Methyltransferase Activity in Human Erythrocytes: Methodological Aspects. Upsala Journal of Medical Sciences. 86(3). 309–318. 10 indexed citations
20.
Flodérus, Ylva, Svante B. Ross, & Lennart Wetterberg. (1981). Erythrocyte catechol‐O‐methyltransferase activity in a Swedish population. Clinical Genetics. 19(5). 389–392. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by U. Groß Breakdown of academic impact, for papers by Antonella Mulas Breakdown of academic impact, for papers by Concetta Meli Breakdown of academic impact, for papers by J. M. Saudubray Breakdown of academic impact, for papers by Xingrao Ke Breakdown of academic impact, for papers by Juan Darío Ortigoza‐Escobar Breakdown of academic impact, for papers by Merçè Pineda Breakdown of academic impact, for papers by In Goo Lee Breakdown of academic impact, for papers by Pierpaola Tannorella
Rankless by CCL
2026